Predicting prognosis in stable angina—results from the Euro heart survey of stable angina: prospective observational study
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.38695.605440.AE (Published 02 February 2006) Cite this as: BMJ 2006;332:262Data supplement
APPENDICES: POSTED AS SUPPLIED BY AUTHOR
Appendix A
Definitions provided automatically by "help text" on electronic Case Record Form
For the purposes of recording ECG abnormalities:
ST depression = depression of the ST segment > 0.5 mm or > 0.05 mv below the isoelectric line
T wave inversion = inversion of the of the T wave of the QRS complex except in leads AVR, V1 and lead III.
Pathological Q waves =Q waves (except in AVR, V1 and III) which are >0.04 sec wide and 0.2mv deep or >20% of the accompanying R wave.
For clinical examination
Clinical signs of heart failure = any or all of the following: elevated venous pressure, hepatomegaly, dependent oedema, crepitations, gallop rhythm, or evidence of cardiac enlargement
For comorbid conditions and risk factors
Hepatic disease = Chronic hepatitis or cirrhosis, or other hepatic disease causing elevation of transaminases more than 3 times the upper limit of normal.
Peripheral Vascular Disease = Claudication either at rest or exertion, amputation for arterial vascular insufficiency, vascular surgery (reconstruction or bypass) or angioplasty to the extremities, documented aortic aneurysm, or noninvasive evidence of impaired arterial flow.
Chronic Renal Failure = Chronic dialysis or renal transplantation or serum creatinine greater than 200 µmol/l.
Chronic Respiratory Disease= Diagnosis previously made by physician, or patient receiving bronchodilators, or values of FEV1<75¨%, arterial pO2<60%, or arterial pCO2>50% in prior studies.
Chronic Inflammatory Conditions = diagnosis of rheumatoid arthritis, systemic lupus erythematosis or other connective tissue diseases, polymyalgia rheumatica etc.
Peptic Ulcer Disease = Active peptic ulcer disease (PUD) or on treatment for PUD Malignancy = Diagnosis within 1 year or active malignancy
Hypertension = Treated hypertension, on anti-hypertensive therapy.
Hyperlipidaemia = Treated hyperlipidaemia, on lipid lowering medication, or specific dietary modification.
Diabetes = Treated diabetes, on insulin or oral diabetic medication, or specific dietary modification.
Family history of premature coronary artery disease (CAD) = A history of angina pectoris, myocardial infarction or sudden death among first-degree relatives under the age of 55 years for male relatives and 65 years for female relatives.
For clinical endpoints
Cardiac Mortality = Death due to myocardial infarction, or complications thereof, cardiac arrhythmia, sudden death, or congestive heart failure.
Cardiovascular mortality =Death due to cardiac causes (including myocardial infarction, cardiac arrhythmia, sudden death and congestive heart failure), cerebrovascular accidents or other vascular causes including bleeding and thrombo-embolic events
Non Fatal Myocardial infarction = Hospitalisation for myocardial infarction where myocardial infarction must involve two of the following:
- Cardiac chest pain at rest lasting >20 minutes, or pulmonary oedema without significant valvular heart disease or known heart failure, or shock, without hypovolaemia or intoxication.
Transient elevation of CPK to twice the upper limit of normal for the laboratory, or CK MB to above the upper limit of normal for the laboratory, or elevation of troponin I or T above the 99th centile of normal in the laboratory.
- ECG series with the evolutionary changes of myocardial infarction. Development and disappearance of localised ST segment elevation, combined with the development of T wave inversion in at least two contiguous leads, and/or the development of pathological Q waves.
NB: If markers of myocardial damage are present the ECG changes could include ST depression, T wave inversion, Loss of R wave progression or new LBBB.
Unstable angina = Acute hospital admission for cardiac chest pain (CCS IV, either pain at rest, or rapidly progressive increase in symptoms) without biochemical marker elevation indicating myocardial infarction.
Hospitalisation for Heart Failure = Hospital admission involving a stay of at least 24 hours for increased severity of heart failure symptoms or signs necessitating either intravenous diuretics, an increase of existing oral diuretics by at least 50%, or commencement on inotropic support.
Cardiovascular hospitalisation = Admission to hospital involving a stay of at least 24 hours for worsening heart failure, acute coronary syndromes, stroke and thrombo-embolic events or other vascular causes
Diabetes = Treated diabetes, on insulin or oral diabetic medication, or specific dietary modification.
Family history of premature coronary artery disease (CAD) = A history of angina pectoris, myocardial infarction or sudden death among first-degree relatives under the age of 55 years for male relatives and 65 years for female relatives.
Appendix B
To develop the clinical risk score, stepwise regression was performed to select the variables most predictive of death or nonfatal MI when the results of investigation were coded as positive or negative rather than including "not performed" as a variable. Forward and backward selection were performed to assess the stability of the selection and the final model fitted to all patients without missing values for the selected variables. A positive (versus negative or inconclusive) result on non-invasive testing was not a significant independent predictor of adverse outcome and was not selected into the model.
A model was developed on a randomly selected 75% of the study patients (the `training set') and was then assessed in the remaining 25% (the `validation set'). The number of subjects included in the final model to create the score was 1896, with 66 events. The variables selected in the model were comorbidity, diabetes, symptom severity, symptom duration, abnormal LV function and ST changes on the resting ECG. The variables selected in the training set were identical to those selected when the same procedure was applied to the entire population.
The Cox regression coefficients of the selected model were then used to define a scoring system that can be used to predict the probability of death or non-fatal MI during the first year after presentation. The Cox proportional hazards model assumes that the event hazard (or rate) at time t, hi(t), for a subject i with covariates x1i , x2i ,…, xKi , is:
hi(t) = ho(t) exp(β1 * x1i + β2 * x2i +…..+ βK * xKi))
In applying these results to our data we have simplified the calculations of the scores by multiplying by 100 each "beta" in the equation above.The combination of all the predictors included in the model weighted by their estimated regression coefficients, (β1, β2, etc) is known as the score, i.e.
scorei = 100 (β1 * x1i + β2 * x2i + β3 * x3i +….. )
The probability that the event of interest occurs within time t (for example 1 year) for patient i can then be calculated as
Probi(event at time t)= 1 – Probi (surviving up to time t)= 1 – Si(t)
Where Si(t)= S0(t) exp(scorei/100)
and S0(t) is the survival probability at time t for somebody with score=0 which is estimated from Cox regression model (likewise the regression coefficients β1, β2, etc.)
The performance of the model on the on the validation set was assessed by computing the c statistic. The c statistic for this model applied to the remaining 25% of the population was 0.74 [95 % CI 0.64 to 0.83].
Related articles
- This Week In The BMJ Published: 02 February 2006; BMJ 332 doi:10.1136/bmj.332.7536.0-c
- Research Published: 14 November 2008; BMJ 337 doi:10.1136/bmj.a2240
- Primary Care Published: 27 November 2003; BMJ 327 doi:10.1136/bmj.327.7426.1267
- Research Published: 06 August 2009; BMJ 339 doi:10.1136/bmj.b3058
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
- UK perspective on the changing landscape of non-invasive cardiac testing
- Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain
- State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease
- A 10-year prognostic model for patients with suspected angina attending a chest pain clinic
- CT coronary angiographic evaluation of suspected anginal chest pain
- Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
- Management of stable angina: summary of NICE guidance
- Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey
- The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial: Can We Deliver on Its Promise?
- Five year prognosis in patients with angina identified in primary care: incident cohort study
- COURAGE to change practice? Revascularisation in patients with stable coronary artery disease
- Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study
- Predictors of Outcome and the Lack of Effect of Percutaneous Coronary Intervention Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction: Results From the OAT (Occluded Artery Trial) Study
- Presentation of stable angina pectoris among women and South Asian people
- Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution
- Stable angina who needs revascularisation?
- The Year in Epidemiology, Health Services Research, and Outcomes Research
- JournalScan
- Risk Scoring for Patients with New Stable Angina